Skip to main content

Table 1 Association between HSPA2 mRNA expression and clinicopathological features of pancreatic cancer

From: Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma

Variables No. of cases (n = 104) HSPA2 mRNA expression P -value
Low (n, %) High (n, %)
Age (years)     0.484
<60 43 21 (48.8) 22 (51.2)  
≥60 61 28 (44.3) 33 (54.1)  
Gender     0.396
Male 82 37 (45.1) 45 (54.9)  
Female 22 12 (54.5) 10 (45.5)  
Tumor size (cm)     0.024
<2 47 32 (68.1) 15 (31.9)  
≥2 57 17 (29.8) 40 (70.2)  
Histological grades     0.012
Well/Moderate 56 32 (57.0) 24 (43.0)  
Poor 48 17 (35.4) 31 (64.6)  
TNM stagea     0.006
IA-IB 66 35 (53.0) 31 (47.0)  
IIA-IIB 38 14 (36.8) 24 (63.2)  
Lymph node metastasis     0.043
No 75 39 (48.0) 36 (52.0)  
Yes 29 10 (44.8) 19 (55.2)  
Vascular invasion     0.062
No 80 39 (48.8) 41 (51.2)  
Yes 24 10 (41.7) 14 (58.3)  
CA19-9 (U/ml)     0.046
<27 27 14 (51.9) 13 (48.1)  
≥27 77 35 (45.5) 42 (54.5)  
Bilirubin (μmol/l)     0.178
<17.1 35 16 (45.7) 19 (54.3)  
≥17.1 69 33 (47.8) 36 (52.3)  
  1. aTNM staging was classified according to the 7th edition of the AJCC cancer staging manual.
  2. HSPA2, Heat shock-related 70 kDa protein 2.